by
msemporda on 04-01-2013 at 01:04 PM
It seems odd to debate the merits of scientific progress and value when people are dying and illness remains the single biggest impediment to human advancement. Well that’s just the reason for Biotech – right? To investigate the possibility of new approaches to treating human suffering and to trial them so they are fit for acquisition and release – or at least that’s what the dogma is supposed to suggest. However, as I learned last week in Barcelona all is not clear with the establishment and the
Read More